Structure and thiazide inhibition mechanism of the human Na-Cl cotransporter

Nature. 2023 Feb;614(7949):788-793. doi: 10.1038/s41586-023-05718-0. Epub 2023 Feb 15.

Abstract

The sodium-chloride cotransporter (NCC) is critical for kidney physiology1. The NCC has a major role in salt reabsorption in the distal convoluted tubule of the nephron2,3, and mutations in the NCC cause the salt-wasting disease Gitelman syndrome4. As a key player in salt handling, the NCC regulates blood pressure and is the target of thiazide diuretics, which have been widely prescribed as first-line medications to treat hypertension for more than 60 years5-7. Here we determined the structures of human NCC alone and in complex with a commonly used thiazide diuretic using cryo-electron microscopy. These structures, together with functional studies, reveal major conformational states of the NCC and an intriguing regulatory mechanism. They also illuminate how thiazide diuretics specifically interact with the NCC and inhibit its transport function. Our results provide critical insights for understanding the Na-Cl cotransport mechanism of the NCC, and they establish a framework for future drug design and for interpreting disease-related mutations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cryoelectron Microscopy*
  • Diuretics / chemistry
  • Diuretics / pharmacology
  • Drug Design
  • Gitelman Syndrome / genetics
  • Humans
  • Sodium Chloride Symporter Inhibitors* / chemistry
  • Sodium Chloride Symporter Inhibitors* / pharmacology
  • Thiazides* / chemistry
  • Thiazides* / pharmacology

Substances

  • Diuretics
  • Sodium Chloride Symporter Inhibitors
  • Thiazides
  • SLC12A3 protein, human